Gustave Roussy shared a post on LinkedIn:
“Gustave Roussy Strengthens Leadership in Precision Medicine
As of January 2026, Prof. Italiano Antoine will join Gustave Roussy full-time in the Department of Therapeutic Innovation and Early Trials (DITEP).
Already engaged since 2020, he has contributed to the development of structuring projects in liquid biopsy and molecular medicine. His full-time arrival will strengthen the deployment of personalized medicine, particularly in the field of sarcomas and rare tumors, in conjunction with the IHU PRISM.
This development illustrates Gustave Roussy‘s ambition to accelerate innovation and the transfer of scientific advances to clinical practice, for the benefit of patients.”
More from Gustave Roussy.